e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Ofer Haviv
Recent news which mentions Ofer Haviv
Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
March 07, 2024
Tickers
EVGN
NEWS
Tags
EVGN
Earnings
Fourth Quarter Earnings
From
Benzinga
Israeli Cannabis Co. Reports Solid Q2 Performance, Nearing Growth Targets
August 17, 2023
Tickers
EVGN
Tags
second quarter earnings
Cannabis
Israel Cannabis
From
Benzinga
Evogene Q1 Revenue Grows 170% YoY, Here Are The Details
May 18, 2023
Tickers
EVGN
SHC
Tags
SHC
premium
Canonic
From
Benzinga
Evogene Q2 Revenue Grows 131% YoY, Here Is What You Need To Know
August 31, 2022
Tickers
EVGN
ICL
Tags
Markets
EVGN
Penny Stocks
From
Benzinga
Evogene Q1 Revenue Decreases 28.82% YoY, What About Debt?
May 26, 2022
Tickers
EVGN
Tags
Benzinga
Earnings
Markets
From
Benzinga
Evogene Reports Wider Loss In 2021, $54M In Consolidated Cash
March 10, 2022
Tickers
EVGN
Tags
Benzinga
financial results
EVGN
From
Benzinga
Evogene Reports Slight YoY Boost In Q3 Revenue, Looks To Turn Subsidiaries Into Public Companies
November 17, 2021
Tickers
EVGN
Tags
Penny Stocks
News
Ofer Haviv
From
Benzinga
Canonic Announces Pre-Launch of Medical Cannabis Products in Israel
August 31, 2021
Tickers
EVGN
Tags
EVGN
Markets
Canonic
From
Benzinga
Evogene Reports $135.000 In Q2 2021 Revenue, Misses Estimates, EPS Beat Projections By $0.02
August 11, 2021
Tickers
EVGN
Tags
Earnings
Markets
EVGN
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.